Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000899243-97-001217
Filing Date
1997-06-27
Accepted
1997-06-27 00:00:00
Documents
14
Period of Report
1997-03-31
SROs
AMEX

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 59514
2 SPLIT-DOLLAR AGREEMENT ALVAREZ EX-10.(P) 10899
3 SPLIT-DOLLAR AGREEMENT BATCHA EX-10.(Q) 10844
4 SPLIT-DOLLAR AGREEMENT FRAME EX-10.(R) 10847
5 SPLIT-DOLLAR AGREEMENT MOULDS EX-10.(S) 10866
6 PATENT LICENSE AGREEMENT EX-10.(Y) 21791
7 SEVERANCE AGREEMENT ALVAREZ EX-10.(II) 15518
8 SEVERANCE AGREEMENT BATCHA EX-10.(JJ) 15506
9 SEVERANCE AGREEMENT FRAME EX-10.(KK) 15478
10 SEVERANCE AGREEMENT MOULDS EX-10.(LL) 15525
11 1997 ANNUAL REPORT EX-13 103230
12 SUBSIDIARIES OF THE COMPANY EX-21 977
13 CONSENT OF DELOITTE & TOUCHE EX-23 625
14 FINANCIAL DATA SCHEDULE EX-27 2251
  Complete submission text file 0000899243-97-001217.txt   296566
Mailing Address
Business Address 3700 MANGUM RD HOUSTON TX 77092 7136818481
GAMMA BIOLOGICALS INC (Filer) CIK: 0000317890 (see all company filings)

EIN.: 741668436 | State of Incorp.: TX | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-10538 | Film No.: 97631310
SIC: 2835 In Vitro & In Vivo Diagnostic Substances